Catalyst Wire Dossier Catalyst Wire Dossier

Dapagliflozin and Saxagliptin

dapagliflozin and saxagliptin · Novadoz Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dapagliflozin and Saxagliptin, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: FDA Approved: DAPAGLIFLOZIN AND SAXAGLIPTIN — Original Application (Novadoz Pharmaceuticals LLC)

See pricing